Does ELIQUIS Cause Haemoglobin decreased? 14 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Haemoglobin decreased have been filed in association with ELIQUIS. This represents 1.0% of all adverse event reports for ELIQUIS.
14
Reports of Haemoglobin decreased with ELIQUIS
1.0%
of all ELIQUIS reports
1
Deaths
7
Hospitalizations
How Dangerous Is Haemoglobin decreased From ELIQUIS?
Of the 14 reports, 1 (7.1%) resulted in death, 7 (50.0%) required hospitalization.
Is Haemoglobin decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELIQUIS. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does ELIQUIS Cause?
Haemorrhage (79)
Gastrointestinal haemorrhage (72)
Dizziness (65)
Rash (51)
Epistaxis (49)
Headache (49)
Dyspnoea (41)
Adverse event (40)
Diarrhoea (37)
Contusion (34)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
RUXOLITINIB (3,297)
ECULIZUMAB (3,028)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
Which ELIQUIS Alternatives Have Lower Haemoglobin decreased Risk?
ELIQUIS vs ELOSULFASE ALFA
ELIQUIS vs ELOTUZUMAB
ELIQUIS vs ELOXATIN
ELIQUIS vs ELRANATAMAB
ELIQUIS vs ELRANATAMAB-BCMM